Oscar Health, Inc. (OSCR) company profile
Close on Nov 17, 2026Market cap $9.21BP/E 21.3Yield –
About Oscar Health
Hospital & Medical Service Plans, SIC 6324
Oscar is a healthcare technology enterprise that provides health insurance and technology solutions. Centered on a proprietary cloud-native platform, the company offers individual and family health plans through Affordable Care Act marketplaces and Individual Coverage Health Reimbursement Arrangements for employers and employees. Its offerings include health plans across standard metal tiers, featuring exclusive provider organization and health maintenance organization networks, virtual care tools, and targeted condition programs. Through its +Oscar segment, the company supplies payors and providers with its Campaign Builder platform for engagement, automation, and predictive analytics. Oscar also operates digital enrollment software, an individual market brokerage, and consumer education resources.
The company's operations are situated in the United States, where it employed roughly 2,305 workers at the end of 2025. During 2025, Oscar provided coverage in 18 states to approximately 2.0 million effectuated members, with substantial concentrations in Florida, Texas, and Georgia, while its Campaign Builder platform served nearly 0.6 million client lives. Additionally, its brokerage services offer supplemental health products across all 50 states. Oscar is based in the United States, although a specific headquarters city is not identified in the provided text.
Summary of the business section of Oscar Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Oscar Health, Inc.
- Founded
- 2012
- Headquarters
- New York, NY
- Address
- 75 Varick Street, 5th Floor 10013
- Phone
- (646) 403-3677
- Website
- healthinsurance.org
- Employees
- 2,305, Dec 31, 2025
- Industry
- Hospital & Medical Service Plans
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, New York, NY
Stock & identifiers
- Ticker
- OSCR
- Exchange
- NYSE
- IPO date
- Mar 4, 2021
- Shares outstanding
- 309M, Jul 31, 2026
- Public float
- $4.50B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1568651
- CUSIP
- 687793109
- ISIN
- US6877931096
- FIGI
- BBG00YMWFTZ2
- Share class FIGI
- BBG00YMWFVT4
- LEI
- 254900AE8KDLFDOPKZ19
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Joshua Kushner | Co-Founder and Vice Chairman, Director | 39,202,681 |
| Mark T. Bertolini | Chief Executive Officer, Director | 7,751,570 |
| Victoria Baltrus | Chief Accounting Officer | 213,631 |
| Richard Scott Blackley | Chief Financial Officer | 1,102,358 |
| Adam McAnaney | Chief Legal Officer | 209,004 |
| Janet Liang | President, Oscar Insurance | 248,697 |
| Alessandrea C. Quane | EVP, Chief Insurance Officer | 507,073 |
| Ranmali Bopitiya | EVP & Chief Legal Officer | 241,488 |
| Steven Wolin | Chief Operating Officer | 102,951 |
| Rajat Taneja | Director | 3,565 |
| Tomer Cohen | Director | 3,565 |
| Eric Jon Larsen | Director | 3,565 |
| David Plouffe | Director | 137,121 |
| William Gassen | Director | 82,840 |
| Sid Sankaran | Director | 818,295 |
| Vanessa Ames Wittman | Director | 112,121 |
| Claremount TW, L.P. | Director | – |
| Thrive Partners VII GP, LLC | Director | 3,916,153 |
| Thrive Capital Partners VII Growth, L.P. | Director | 6,155,222 |
| Thrive Partners II GP, LLC | Director | – |
| Thrive Partners III GP, LLC | Director | 39,202,681 |
| Thrive Partners VII Growth GP, LLC | Director | 6,343,617 |
| Thrive Capital Partners III, L.P. | Director | – |
| Claremount VII Associates, L.P. | Director | – |
| Thrive Capital Partners II, L.P. | Director | – |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Mr Bertolini | $1.15M | $5.33M | $7.40M | $41 | $100 |
| FY2025 Mr Schlosser | $0 | $0 | $7.40M | $41 | $100 |
| FY2024 Mario Schlosser | $0 | $0 | $6.23M | $39 | $91 |
| FY2024 Mark Bertolini | $915.00K | $54.33M | $6.23M | $39 | $91 |
| FY2024 Mr Bertolini | $915.00K | $54.33M | $6.23M | $39 | $91 |
| FY2024 Mr Schlosser | $0 | $0 | $6.23M | $39 | $91 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Option awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|---|
| Mark T. Bertolini Chief Executive Officer | $619.18K | – | – | – | $169.04K | $361.09K | $1.15M | +26% |
| Mario Schlosser President of Technology and Chief Technology Officer | $600.00K | – | $6.14M | – | $546.00K | $28.91K | $7.31M | -33% |
| Scott Blackley Chief Financial Officer | $600.00K | – | $3.69M | – | $436.80K | $29.91K | $4.75M | -13% |
| Janet Liang President of Oscar Insurance | $512.50K | $2.80M | $4.94M | $1.50M | $465.22K | $179.91K | $10.40M | – |
| Adam McAnaney Chief Legal Officer | $512.50K | $335.00K | $4.07M | $1.90M | $279.13K | $29.91K | $7.13M | – |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Mar 4, 2021
- Offer price
- $39.00
- Securities offered
- 37,041,026
- Gross proceeds
- $1.44B
- Exchange
- NYSE
- Lock-up ends (est.)
- Aug 31, 2021
“Per Share Total Initial public offering price $ 39.00 $ 1,444,600,014.00 Underwriting discounts and commissions(1) $ 1.95 $ 72,230,000.70 Proceeds, before expenses, to us $ 37.05 $ 1,348,321,599.30 Proceeds, before expenses, to the selling stockholders $ 37.05 $ 24,048,414.00 (1) See “Underwriting” for a descriptio”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had approximately 2,305 employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Mar 4, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Mar 3, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |
| Dec 17, 2020 | Name change | Name changed from Mulberry Health Inc. to Oscar Health, Inc. |
See a number that looks wrong?